Product image of Helicid Neo (Omeprazole) supplied by GNH India

Helicid Neo

Active Ingredient:
Omeprazole
Origin:
EU

Helicid Neo (Omeprazole)

Helicid Neo is an oral formulation that contains the proton pump inhibitor omeprazole as its active ingredient. It belongs to the gastrointestinal acid reducer class and is marketed in the European Union. The product works by irreversibly inhibiting the gastric H+/K+ ATPase, thereby reducing stomach acid production. Helicid Neo is used under medical supervision for conditions related to excess gastric acidity.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Helicid Neo is indicated for several acid‑related gastrointestinal conditions. It is commonly prescribed as part of a therapeutic regimen to manage the following:

  • Gastro‑esophageal reflux disease (GERD)
  • Peptic ulcer disease, including duodenal and gastric ulcers
  • Prevention of NSAID‑induced gastric ulcers
  • Part of combination therapy for Helicobacter pylori eradication
  • Maintenance therapy to prevent ulcer recurrence after healing

Side Effects

Side effects of Helicid Neo vary in frequency and severity. Most patients experience mild, transient symptoms, while rare events may require medical attention.

Common

  • Headache
  • Diarrhea or loose stools
  • Nausea or abdominal discomfort
  • Flatulence
  • Constipation
  • Dry mouth

Serious

  • Severe allergic reactions (rash, swelling, difficulty breathing)
  • Clostridioides difficile‑associated colitis
  • Low magnesium levels (hypomagnesemia)
  • Liver enzyme elevations
  • Bone fractures with long‑term use

Precautions & Warnings

Before starting Helicid Neo, certain health considerations should be reviewed. Patients should discuss the following with their healthcare provider:

  • History of liver disease or impaired hepatic function
  • Known hypersensitivity to omeprazole or other proton pump inhibitors
  • Existing low magnesium levels or risk factors for electrolyte imbalance
  • Use of long‑term therapy, especially in the elderly, due to fracture risk
  • Pregnancy or breastfeeding status, as safety data are limited
  • Concomitant use of medications that require an acidic environment for absorption

Avoid Interactions

Helicid Neo can affect the pharmacokinetics of several other drugs. Awareness of these interactions helps to avoid reduced efficacy or increased toxicity.

Avoid

  • Antiplatelet agents such as clopidogrel (reduced activation)
  • HIV protease inhibitors (e.g., atazanavir, nelfinavir) that need acidic pH for absorption
  • Certain antifungal agents (e.g., ketoconazole, itraconazole)

Use with caution

  • Warfarin (potential increase in INR)
  • Digoxin (altered absorption)
  • Methotrexate (possible increased serum levels)
  • Diazepam and other benzodiazepines (enhanced effects)

Frequently Asked Questions

Helicid Neo contains omeprazole, a proton pump inhibitor that reduces gastric acid secretion.

It is used for gastro‑esophageal reflux disease, peptic ulcer disease, NSAID‑induced ulcer prophylaxis, and as part of Helicobacter pylori eradication therapy.

Omeprazole irreversibly inhibits the H+/K+ ATPase enzyme (gastric proton pump) in parietal cells, suppressing acid production.

Medications such as ketoconazole, itraconazole, and certain HIV protease inhibitors may have reduced absorption and should be avoided or timed separately.

Common side effects include headache, nausea, diarrhea, constipation, flatulence, and dry mouth.

Serious reactions can include severe allergic responses, Clostridioides difficile colitis, low magnesium levels, liver enzyme changes, and increased risk of bone fractures with long‑term use.

Patients with liver impairment should discuss use with their healthcare provider, as dosage adjustments or monitoring may be needed.

Safety data are limited; pregnant or nursing individuals should consult a physician before using Helicid Neo.

Short‑term use is generally safe; long‑term therapy should be monitored for potential risks such as fractures, magnesium deficiency, and kidney issues.

Take the missed dose as soon as remembered unless it is close to the time of the next scheduled dose; do not double the dose.

Yes, Helicid Neo may increase INR levels; patients on warfarin should have their coagulation status monitored.

The regulatory status varies by country; in some EU regions it may require a prescription, while in others it could be available OTC.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.